Hetrombopag
A medication used to treat thrombocytopenia
Hetrombopag is a medication used primarily for the treatment of thrombocytopenia, a condition characterized by abnormally low levels of platelets in the blood. It is classified as a thrombopoietin receptor agonist, which means it stimulates the production of platelets by activating the thrombopoietin receptor.
Mechanism of Action[edit | edit source]
Hetrombopag works by mimicking the action of thrombopoietin, a natural hormone that regulates platelet production. It binds to and activates the thrombopoietin receptor on megakaryocytes, the precursor cells in the bone marrow that develop into platelets. This activation leads to increased production and release of platelets into the bloodstream, thereby alleviating the symptoms of thrombocytopenia.
Uses[edit | edit source]
Hetrombopag is primarily indicated for patients with chronic immune thrombocytopenic purpura (ITP) who have not responded adequately to other treatments. It may also be used in other conditions associated with low platelet counts, such as aplastic anemia and certain types of chemotherapy-induced thrombocytopenia.
Administration[edit | edit source]
Hetrombopag is administered orally, and the dosage is typically adjusted based on the patient's platelet count and response to the medication. Regular monitoring of platelet levels is essential to ensure the effectiveness of the treatment and to avoid potential complications such as excessive platelet production.
Side Effects[edit | edit source]
Common side effects of Hetrombopag include headache, fatigue, and nausea. More serious side effects can occur, such as liver function abnormalities and thromboembolic events, which require careful monitoring and management.
Contraindications[edit | edit source]
Hetrombopag is contraindicated in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with liver impairment, as the drug can affect liver function.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
